PMDA posts MHLW notice on revising precautions for regenerative medicine products (Mar 5, 2025)
使用上の注意の改訂指示通知（再生医療等製品）2025年3月5日付（厚生労働省より発出）を掲載しました
Published: 2025-03-05 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · First detected by this dashboard: 2026-08-06
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
The PMDA Safety Updates page lists a notice, issued by the Ministry of Health, Labour and Welfare and dated March 5, 2025, instructing revisions to the 'precautions for use' (package insert precautions) of regenerative medicine products. This is a government announcement posted to the PMDA safety information site; the specific products and revised content are not stated in the provided metadata.
Business Impact
Marketing authorization holders of regenerative medicine products may need to consider whether their product labeling is affected. Affected products and the extent of any required changes could not be determined from the available information.
Recommended Action
Review the official PMDA page and the underlying MHLW notice in Japanese to identify which products are covered and what revisions are instructed.